ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics Inc (QB) (NWBO)

0.246095
-0.00141
( -0.57% )
Updated: 13:50:16

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.246095
Bid
0.2455
Ask
0.2472
Volume
1,719,946
0.2421 Day's Range 0.253
0.24 52 Week Range 0.6489
Market Cap
Previous Close
0.2475
Open
0.25
Last Trade
800
@
0.246095
Last Trade Time
13:50:16
Financial Volume
$ 424,203
VWAP
0.246637
Average Volume (3m)
3,347,826
Shares Outstanding
1,297,445,623
Dividend Yield
-
PE Ratio
-3.43
Earnings Per Share (EPS)
-0.05
Revenue
1.93M
Net Profit
-64.37M

About Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is i... Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Northwest Biotherapeutics Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker NWBO. The last closing price for Northwest Biotherapeutics (QB) was $0.25. Over the last year, Northwest Biotherapeutics (QB) shares have traded in a share price range of $ 0.24 to $ 0.6489.

Northwest Biotherapeutics (QB) currently has 1,297,445,623 shares outstanding. The market capitalization of Northwest Biotherapeutics (QB) is $321.12 million. Northwest Biotherapeutics (QB) has a price to earnings ratio (PE ratio) of -3.43.

NWBO Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.003905-1.5620.250.25810.2422508270.24580971CS
4-0.006405-2.536633663370.25250.310.2437176200.26082966CS
12-0.033805-12.07752768850.27990.3580.2433478260.27044243CS
26-0.068805-21.84979358530.31490.3580.2426895800.27745568CS
52-0.290105-54.10387914960.53620.64890.2423566530.33583374CS
156-0.453905-64.84357142860.72.050.2422669620.62354244CS
2600.08609553.8093750.162.540.00525057070.8160217CS

NWBO - Frequently Asked Questions (FAQ)

What is the current Northwest Biotherapeutics (QB) share price?
The current share price of Northwest Biotherapeutics (QB) is $ 0.246095
How many Northwest Biotherapeutics (QB) shares are in issue?
Northwest Biotherapeutics (QB) has 1,297,445,623 shares in issue
What is the market cap of Northwest Biotherapeutics (QB)?
The market capitalisation of Northwest Biotherapeutics (QB) is USD 321.12M
What is the 1 year trading range for Northwest Biotherapeutics (QB) share price?
Northwest Biotherapeutics (QB) has traded in the range of $ 0.24 to $ 0.6489 during the past year
What is the PE ratio of Northwest Biotherapeutics (QB)?
The price to earnings ratio of Northwest Biotherapeutics (QB) is -3.43
What is the cash to sales ratio of Northwest Biotherapeutics (QB)?
The cash to sales ratio of Northwest Biotherapeutics (QB) is 113.33
What is the reporting currency for Northwest Biotherapeutics (QB)?
Northwest Biotherapeutics (QB) reports financial results in USD
What is the latest annual turnover for Northwest Biotherapeutics (QB)?
The latest annual turnover of Northwest Biotherapeutics (QB) is USD 1.93M
What is the latest annual profit for Northwest Biotherapeutics (QB)?
The latest annual profit of Northwest Biotherapeutics (QB) is USD -64.37M
What is the registered address of Northwest Biotherapeutics (QB)?
The registered address for Northwest Biotherapeutics (QB) is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
Which industry sector does Northwest Biotherapeutics (QB) operate in?
Northwest Biotherapeutics (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MNIIManati Inds Inc (CE)
$ 0.25
(24,999,900.00%)
100
EWGFFEat Well Investment Group Inc (CE)
$ 0.04
(3,999,900.00%)
100
ELIQQElectriq Power Holdings Inc (CE)
$ 0.20
(199,900.00%)
100
BETSFBit Brother Ltd (CE)
$ 0.0002
(19,900.00%)
255
SUNCSuncast Solar Energy Inc (CE)
$ 0.0001
(9,900.00%)
71.97k
ATHXQAthersys Inc New (CE)
$ 0.000001
(-99.90%)
4.8k
STTOSITO Mobile Ltd (CE)
$ 0.0002
(-99.90%)
278
ZHCLFZenith Capital Corporation (CE)
$ 0.0001
(-99.80%)
4.72k
SHMPNaturalShrimp Incorporated (CE)
$ 0.000001
(-99.80%)
84.27k
VAXXVaxxinity Inc (CE)
$ 0.0001
(-99.80%)
4.31k
HMBLHUMBL Inc (PK)
$ 0.0003
(-25.00%)
150.09M
IJJPIJJ Corporation (PK)
$ 0.00015
(-40.00%)
131.73M
GTVHGolden Triangle Ventures Inc (PK)
$ 0.0003
(-14.29%)
68.53M
VPERViper Networks Inc (PK)
$ 0.0003
(20.00%)
62.45M
HCMCHealthier Choices Management Corporation (PK)
$ 0.000001
(0.00%)
61.91M

NWBO Discussion

View Posts
eagle8 eagle8 10 minutes ago
Thank you.

GLTU
👍️0
EasyEarnie EasyEarnie 18 minutes ago
As someone who only has 60k shares (wish I had way more), it’s mind blowing to me that some of you guys casually throw out 50k, 100k, 200k+ buys and I’m jealous! Glad you all are able to have that level of financial security, while also supporting a great company.

Saw this recently, “The loudest moves are the weakest. Move in silence, execute with precision. By the time they find out, it’s already too late.”

Hoping that’s LP soon and those 50k+ buys pay handsomely!
👍️ 3 🪠 1 ⛽️ 1
learningcurve2020 learningcurve2020 37 minutes ago
Geez, both brothers. R.I.P.

https://www.yahoo.com/entertainment/neil-peart-brother-dies-same-145350146.html
👍️0
martyDg martyDg 40 minutes ago
That's sound VVVVVVVVEEEEEEEERRRRRRRRRYYYY Positive!

"They are pushing forward" What else can he say? What else could he say? "Backward"? Of course not. His job is to keep things positive or at least neutral. What he said is very common and no substance at all.
👍 1 💯 1 📌 1 🚫 1
manibiotech manibiotech 53 minutes ago
Translates to ....."we don't like difficult questions and won't reply to them"
🚫 1 🩱 1
learningcurve2020 learningcurve2020 54 minutes ago
Glad you caught that. Could easily interpret that as an uphill battle. I’m sure we’ll hear more in the summer. 🙄🤷‍♀️
👍️0
JTORENCE JTORENCE 1 hour ago
goldfinger "They are pushing forward" . Like the company was going to be unrecognizable by the fall? What happened there?
📌 1 🚫 1
underpar71 underpar71 1 hour ago
I have a 50k share buy in at .245 so you can be sure MMs won't let it get there until about 330PM.
👍️ 2
underpar71 underpar71 1 hour ago
What?
👍️ 1
learningcurve2020 learningcurve2020 1 hour ago
Disciples like to keep their flock in a bubble here, but I think it’s important they really see what’s going on out there.

>>Glioblastoma is the most common type of brain tumor in adults, with about 12,000 cases in the United States each year. Despite the disease's prevalence, outcomes for patients with glioblastoma have barely improved in the last 20 years.

https://medicalxpress.com/news/2025-03-suppressing-key-protein-immunotherapy-glioblastoma.html#google_vignette
👍️0
manibiotech manibiotech 1 hour ago
Listen to last ASM . Lot of things were said without committing to any milestone with any deadline attached and that's why SP didn't move . But obvious few were jovial . 
👍️0
learningcurve2020 learningcurve2020 1 hour ago
1 and 4, 2 and 3 are the same thing.
👙 1 🚫 1 🤷 1
underpar71 underpar71 2 hours ago
What? You asked nicely (weren't mean 🤬)and he told you what you wanted to hear. That's what I read from your post. "They are pushing forward"....they have been saying that for 5 years since data lock. Where is the substance? How did zero information from DI get you to "we are really close"?
👍️ 5 👙 1 👚 1 💯 2
GoodGuyBill GoodGuyBill 2 hours ago
Every point in my statement was factual. Naysayers like yourself said none of the accomplishments NWBO has made would occur. Every damn one of them happened. Now you are saying but they're too slow... (Point #5: etc, etc, etc. Lol).

How many times over the last decade have the naysayers predicted:
1. A medical journal would never publish the results of the bogus DCVax-L P3 trial?
2. The DCVax-L P3 SAP would never be completed?
3. DCVax-L P3 trial itself would NEVER be completed?
4. A medical journal would never publish the results of the DCVax-L P3 trial?
5. etc, etc, etc
👍️ 6 💯 3 🔥 1
manibiotech manibiotech 2 hours ago
We unless he told you about what the delay is with MHRA and there has been no hiccup ( all the inspections are successfully completed)? Is FDA application ready - if not why not ? Do they have definite fool proof plan for non dilutive capital/ partnership/licensing etc  ? Not sure anything else said in 10K will make a 1 cent difference in the SP at this late stage . That's my opinion . And I said the same thing on the  last ASM weekend,  that what was said won't move SP a single bit - which is what happened as well. 
🚫 1 ⛔️ 1
TheFollower TheFollower 2 hours ago
You're right! Thanks for your info. Appreciated.
👍️ 1
jesster64 jesster64 2 hours ago
Has responding to them worked or are they increasing? They get paid by the post I would think.
👍️0
goldfinger goldfinger 2 hours ago
I got a nice response back from Dave Innes today.To me the next 10k will explain alot it gave me renewed thoughts and great hopes.The cry babies on here should write but you can not be mean in your questions or you probably will not get a response.Be nice i got a good response.The response came back in like a half hour.Some will say its all lies but that is why you feel the way you do.You slam people but expect the best back.Stop the crying and communicate.10k will be out before end of the month.They are pushing forward.To me that is news and all they can share for now.I did get a couple of places to go and reread over past company statments.I think we are really close.
👍️ 21 🔥 2 😁 6 😂 2 🚀 2 🤣 1 🤷 1
jesster64 jesster64 2 hours ago
"Why give credence to those posters who want to destroy the stock? By responding, YOU are giving them credibility and one of their missions is accomplished (you creating a dialog with them)."
exactly. What is posted on this board doesn't move the SP and responding makes them appear relevant.
👍️0
learningcurve2020 learningcurve2020 2 hours ago
So, you’re saying that despite all the pumping for the last fifteen years that DCVAX really never stood a chance to commercialize. Got it.

It still hasn’t.
>>which it didn’t until in the hands of NWBO.
💯 1
FeMike FeMike 2 hours ago
How insecure do you have to be to go out of your way to ridicule others?

Why didn't you call him out for ridiculing and insulting me for having the audacity to refute his claim that Northwest would have an FDA submission completed by February?

It's okay for him to ridicule me, but when it turns out I'm right and I call him out on it, that's when it's not okay, hmm?

Glass houses, and what not.
Does it make you feel strong and important buddy?
It makes me feel right. A feeling, I am sure, you are quite unfamiliar with.
👍️ 1
learningcurve2020 learningcurve2020 2 hours ago
And besides, new investors have their stellar website to go to. 🙄🤷‍♀️
👍️0
XMaster2023 XMaster2023 2 hours ago
Speaking out and confronting the fudsters BS is our right. Ignoring bullies is a good strategy if you want to be bullied. Did the bullies ignore you when you were in school? Those who pushed back, usually were ignored by the bullies.
I’m not a very compliant person. My choice.
I do not agree that ignoring them is a good strategy.
👍️ 3
manibiotech manibiotech 2 hours ago
"... as such and is later..."
👍️0
manibiotech manibiotech 2 hours ago
Not true at allNWBO didn't discover dendritic cells or their role in human physiology . That research was funded by universities and grants . Most of new basic research happens and such and is later bought or licensed and further developed by commercial companies .
👍️ 1
Doc logic Doc logic 2 hours ago
HappyLibrarian,

Funding research by itself isn’t really true altruism as it research by itself with personalized cell therapies which require much more to arrive at the market place patient. This holds true unless the research also includes ways to mass produce the individualized treatments which it didn’t until in the hands of NWBO. If getting research to the clinic is the end game then getting someone else besides researchers usually is required to get it by there, aka NWBO/Flaskworks/Advent in this case. Another form of altruism is investing with the knowledge that the investor could lose everything but is willing to do so to advance the product towards actual regular patient availability and use. Best wishes.
👍 2
KRISGO KRISGO 2 hours ago
I got so excited for the weekend pump that I couldn’t sleep, constantly checking messages. And, as usual, when I woke up, there was no news, and the price hadn’t moved. It kind of feels like being stuck in a prison…😔
👍️ 2
BurtMacklinfbi BurtMacklinfbi 3 hours ago
How insecure do you have to be to go out of your way to ridicule others? Does it make you feel strong and important buddy? Man, what a way to live life.
👍️ 7 👎️ 1 💯 1
manibiotech manibiotech 3 hours ago
And distribution of payments from specials between NWBO and Advent and based on what contract/terms? 
👍️0
underpar71 underpar71 3 hours ago
And no reporting on specials revenue, number of patients treated or the extension of survival
👿 1 ☠️ 1
manibiotech manibiotech 3 hours ago
And millions paid to Advent with no ongoing trial 
👿 1 ☠️ 1
underpar71 underpar71 3 hours ago
And follow the breadcrumbs.
👍 1 👿 1 💀 1 💯 1 😷 1 🤥 1
manibiotech manibiotech 3 hours ago
You mean .... if you "read between the lines"
👍️ 2 👿 1 💀 1
manibiotech manibiotech 3 hours ago
Sure 
And who told you this ??
👿 1 ☠️ 1
FeMike FeMike 3 hours ago
9-IronMike, NWBO is largely done with getting BLA ready for FDA; they just want to apply any minor modifications learned from MHRA submission. So, they'll press the button in a couple of months for FDA submission.

Just wanted to check in and see where we're at on this WideEyed.

I assume NWBO has completed their secret submission to the FDA?

No way FUDster Mike was right again, is there?
👧 1 👶 2 👿 1 💀 2 😃 1 🚽 2 🧚 1 🪠 1
JTORENCE JTORENCE 3 hours ago
Lykiri Ten minutes to the person that has revolutionized cancer treat. What a friggin joke. My guess is there will be additional time given to her if approval comes ,hopefully before the symposium.
👍️ 2 👿 1 ☠️ 1
Guzzi62 Guzzi62 3 hours ago
Who would potential investors be?

Reading about NWBO in the press? They will have to dig deep, really deep.

I think the last press was good old Les on Biznews.

On NWBO website the latest news is from Dec2024: Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing.

https://nwbio.com/
👍️0
improving improving 3 hours ago
The courts still apply something called the "Business Judgment Rule" avoiding the investor "strike suits" you speak of. This lets companies concentrate their efforts on business instead of nuisance suits. I doubt management will losing much sleep over the "lawsuit" you mention. They'll be too busy increasing your ROI !

___________________________________________
They will get slapped with a lawsuit later this year. There is no hiding. Some of the shareholders that care about highest level of business ethics, execution, and importantly ROI will not tolerate this anymore. They (management) have been given enough leeway and benefit of doubt over the last decade or so.
👍️ 3
underpar71 underpar71 3 hours ago
The Only reason I am buying more is because the MHRA can change everything with an approval. No faith in the communication from the company. Per the MHRA:
MHRA meeting dates: 27 and 28 March 2025
If we do not get a decision within a week of these dates I will be starting to sell and move on.
👿 1 ☠️ 1
underpar71 underpar71 3 hours ago
No news, no volume, no interest or awareness to the general investing public. No PR's of ANY activity from the company in almost a year. That equals .24
👍️ 2 👿 1 💀 1 🤥 1 🤧 1
attilathehunt attilathehunt 3 hours ago
If we do not respond, new investors will assume the crap the fudsters post is true.


If a potential investor is prudent, then they will see right through the fudsters.

And contrary, if they do believe the fudsters we are probably better without them.

Why give credence to those posters who want to destroy the stock? By responding, YOU are giving them credibility and one of their missions is accomplished (you creating a dialog with them).
💯 1
theorysuit theorysuit 4 hours ago
Trial was done in 2018. It is now 2025. Over 1.3B share outstanding. Debt. No Cash. No approvals.
Share price From $1480 to $0.24....that is a fantastic accomplishment. Shareholder wealth destruction over many many iteratons of shareholders. Keep pumping though!

dilution dilution. Hey LP built out her CDMOs twice....on shareholder backs. That is an noteworthy accomplishment .

You needed a damn journal article to even Submit? Why? Because the ceo is building out CDMOs instead of running a proper trial and you need the journal article to explain this damn monstrousity of a trial? Is that why they submit to small market UK when the FDA is a 10 minute drive from HQ?

What's good here? This has got to be the world record from Trial completion to 1st Approval decision.......don't say i didn't warn you sheep of pumpers like this.
👿 1 🚽 1 ☠️ 2
underpar71 underpar71 4 hours ago
Right, great information for all 12 people that read it.
👍️ 1 👿 1 ☠️ 1
FeMike FeMike 4 hours ago
And when nothing is gleaned, DI will ask you if you read it carefully.

"Did you read the K we just put out? We thought there was a lot of good news in it."
👿 1 🚽 1 🪠 1 ☠️ 1
learningcurve2020 learningcurve2020 4 hours ago
☘️☘️☘️🥩🥩🥩💆‍♂️💆‍♂️💆‍♂️
👿 1 ☠️ 1
learningcurve2020 learningcurve2020 4 hours ago
Didn’t think so. 🫃🏻🤷🏻‍♂️
👿 1 ☠️ 1
learningcurve2020 learningcurve2020 4 hours ago
Can we all at least agree that Feuerstein won the bet with Bigger?
👍️ 1 👿 1 ☠️ 1
ilovetech ilovetech 4 hours ago
Buy new reading glasses. Dude.
👍️ 5 💯 1
Investor082 Investor082 4 hours ago
Right, that’s why they continue to lie about their US and FDA pathway. UK approval wont change much in terms of attractiveness towards generating free cash flow, but continue to pump. They have mislead shareholders around other regulatory applications as well as reimbursements in the UK.

They will get slapped with a lawsuit later this year. There is no hiding. Some of the shareholders that care about highest level of business ethics, execution, and importantly ROI will not tolerate this anymore. They (management) have been given enough leeway and benefit of doubt over the last decade or so.
👿 1 ☠️ 1
FeMike FeMike 4 hours ago
Holy shit dude use a period.
👙 1 👿 1 ☠️ 1

Your Recent History

Delayed Upgrade Clock